The Maryland Drug Discovery and Development Network (MDDDN) is a new initiative that has been developed by the principal life sciences research institutions of the University System of Maryland (USM), Johns Hopkins University, and selected Community Colleges.
The purpose of the Network is to increase overall awareness, both here in Maryland and around the world, of our State’s considerable resources to support and collaborate with those involved with drug discovery and development. The rationale for development of this network is that there are many distributed resources and it may be difficult for a bioscience company to identify and access public and private resources during the drug discovery and development lifecycle.
Over time, the MDDDN will be expanding the list of resources at institutions of higher education as well as federal and commercial entities within the State that fall within the six primary areas of research and development: pre-clinical research, clinical research, regulatory support, manufacturing, workforce training, and research facilities.
Those seeking services and collaborations in drug discovery and development should contact MDDDN members to obtain information and access guidance.